Market Overview
Laser Hair Loss Treatment Market is predicted to reach at a CAGR of 12.0% during the forecast period (2024-2031). Laser hair loss treatment is a safe light/heat treatment method researched for various health conditions.
It is used to treat androgenetic alopecia, also known as pattern baldness, a genetic form of hair loss that affects both men and women.
Market Scope
| Metrics | Details |
| Market CAGR | 12% |
| Segments Covered | By Product Type, By Application, By End-User, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
To know more Insights Download Sample
Market Dynamics
The factors expected to drive the global laser hair loss treatment market are the advantages laser provides in hair loss treatment.
The advantages laser provides in hair loss treatment is expected to drive the market growth in the forecast period
Approximately 80 million Americans suffer from alopecia or hereditary hair loss. Hair loss can be caused by various factors, including male pattern baldness, female pattern baldness, hormonal imbalance, cancer treatments, stressful events, childbirth or illness, medications, nutritional deficiencies, and many others. There have been various advancements in laser hair loss treatments. Numerous treatment options are available, including laser hair growth devices such as the laser cap, comb, and hair growth band. Modern scalp treatments and medically compliant laser hair growth treatments that stimulate hair follicle growth are among the safest and most effective options for reducing or stopping hair loss and encouraging vigorous hair growth and new regrowth. Advanced Laser Therapy is one such revolutionary hair retention procedure that will aid in preventing and regrowth of hair. Low-level laser therapy (LLLT), also known as cold laser therapy or red light therapy, involves the introduction of photons into the scalp tissues. These photons are absorbed by the weak cells and stimulate hair growth. Low-level laser therapy is a popular, less invasive, and widely accepted procedure. The red light from laser hair growth devices can rejuvenate thinning hair follicles and prolong the anagen growth cycle by increasing blood circulation and stimulating hair growth factors.
Limitations associated with laser is expected to hamper the market growth
There are different limitations associated with laser treatment for hair loss. For instance, the cost factor is that clinical laser hair loss treatments can cost thousands of dollars per year. Treatment often necessitates several sessions per week for several months to see results. Although the number of sessions may decrease, most provide The procedure could be less effective for people in the advanced stages of hair loss than for those in the early stages.
Certain medications may interact with it. Laser therapy should not be used on people who are taking photosensitizing medications. Photosensitization is a chemical change to the skin that increases sensitivity to light. Doctors recommend continuing treatments for the rest of life. Because laser devices are classified as medical devices by the FDA, they are not subjected to the same level of testing and scrutiny that medicines are subjected to prior to approval. Long-term safety and effectiveness have yet to be established.
COVID-19 Impact on Market
Since COVID-19 in early 2020, there has been a long list of medical side effects. Pulmonary, cardiovascular, and clotting disorders are well-known examples. There have also been skin changes, including hair loss. Due to COVID in the spring of 2020 in the New York area, they presented with significant, diffuse hair loss on their scalp. It is unclear whether this is a classic case of telogen effluvium or a direct hair loss caused by COVID.
Infection with COVID-19 is now a frequent and common cause of acute telogen effluvium. Many people experience hair loss in the months following a COVID-19 infection. For instance, more than 20% of people hospitalized with COVID-19 experience hair loss within 3 to 6 months of discharge. Other studies involving people with milder symptoms suggest that hair loss after COVID-19 is more common. Hence, the increasing number of people facing hair loss problems due to COVID 19 is expected to increase the demand for laser hair loss treatment.
Market Segment Analysis
Based on product type, the laser helmet segment is expected to dominate the market growth in the forecast period
A laser helmet for hair is one of the most convenient, effective, and hands-free devices for reducing hair loss and increasing hair re-growth. Both men and women have used laser helmets, which use laser light to stimulate hair growth with clearly positive results. It is an advanced laser hair restoration treatment that uses laser light to stimulate blood circulation throughout the scalp to stop hair loss, thicken existing hair, and grow new hair. Because it is hands-free, a laser helmet for hair loss treatment is highly effective in promoting overall scalp and hair health, is more convenient to use. It helps to stop thinning hair and regrow hair in home comfort by wearing a high-tech laser helmet and avoiding surgery. Many companies are manufacturing laser helmets due to their increasing demand and are expected to drive market growth in the forecast period.
For instance, on October 12th, 2020, LG Electronics Inc. launched a hair loss treatment device in South Korea. LG Pra. L MediHair was approved as a laser apparatus for medical use by Seoul's drug safety ministry. It was also cleared by the US Food and Drug Administration (FDA) as a Class II device for home use. The hair growth helmet is based on Low-Level Light Therapy (LLLT), approved by the FDA to treat androgenetic alopecia. Some laser helmets on the market include the LH272 Laser Hair Growth Helmet, the iRestore Laser Hair Growth System, the iGrow Laser Hair Growth Helmet, the Theradome PRO LH80 Laser Helmet, and the Lescolton Hair Growth Laser Helmet.
Market Geographical Share
North America region is expected to hold the largest market share in the global laser hair loss treatment market
The increasing incidence of alopecia in this region is expected to drive market growth.
In the United States, one in every 500 to 1,000 people suffers from alopecia areata. It is one of several recognized types of alopecia; after androgenetic alopecia, alopecia areata is the second most common (male-pattern baldness in men and female-pattern baldness in women). According to the National Alopecia Areata Foundation, alopecia areata affects about 2% of the population. The condition affects approximately five million people in the United States. It affects people of all ages and races, and it frequently starts in childhood.
On April 9th, 2018, the FDA has approved a laser phototherapy device for male hair restoration. Theradome has received FDA approval to market its LH80 PRO laser phototherapy hair restoration device to men in the United States. Theradome's LH80 PRO Laser Helmet, which uses laser phototherapy to stimulate hair growth, has been FDA-approved for use by men in the United States.
Market Companies and Competitive Landscape
The global laser hair loss treatment market is moderately competitive with acquisitions, mergers, and product launches. Some of the key in the market are Apira Science, Inc., Capillus, iRestore, Lexington International, LLC., Cosderma, M/s Modern Aesthetics, Theradome Inc., Shenzhen Lescolton Electric Appliance Co., Ltd., and Eclipse Aesthetics, LLC.
Lexington International, LLC.
Overview: Lexington International, LLC is a company that manufactures and develops advanced phototherapy medical devices for home use. The company was founded in 2000. Since then, the company has sold over 1.8 million laser devices in 170 countries. The company began a comprehensive research program to obtain FDA approval for medical devices rather than cosmetic devices. The company’s Laser Helmet is sold under the brand name HairMax.
Product Portfolio: The company manufactures laser bands, laser combs, and laser caps.
Key Development:
On June 20, 2018, The RegrowMD Laser 272 Laser Cap was approved by the FDA for the treatment of androgenetic alopecia (hereditary and hormonal hair loss) in both men and women.
